Management of an opioid-impaired anaesthetist by implantable naltrexone

Author： Hulse Gary   O'Neil George   Arnold-Reed Diane  

Publisher： Radcliffe Press

ISSN： 1465-9891

Source： Journal of Substance Use, Vol.9, Iss.2, 2004-04, pp. : 86-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Combination Very Low-Dose Naltrexone–Clonidine in the Management of Opioid Withdrawal

By Mannelli Paolo   Peindl Kathleen   Wu Li-Tzy   Patkar Ashwin A.   Gorelick David A.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 3, 2012-05 ,pp. : 200-205

Informa Healthcare

Access to resources Recommend Favorite

Naltrexone and Pharmacy Benefit Management

By Harris Katherine M   Thomas Cindy  

Journal of Addictive Diseases, Vol. 23, Iss. 4, 2004-06 ,pp. : 11-29

Haworth Press

Access to resources Recommend Favorite

Risk of opioid death in patients with naltrexone implants

By  

Reactions Weekly, Vol. 1, Iss. 1143, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Sustained-release naltrexone: novel treatment for opioid dependence

By Comer Sandra D   Sullivan Maria A   Hulse Gary K  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1285-1294

Informa Healthcare

Access to resources Recommend Favorite

Differential antagonism of the rate-decreasing effects of -opioid receptor agonists by naltrexone and norbinaltorphimine

By Powell K.R.   Holtzman S.G.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 21-28

Elsevier

Access to resources Recommend Favorite